Adult height in children with short stature and idiopathic delayed puberty after different management.
By retrospectively collecting data from nine Italian centres of pediatric endocrinology, we assessed the different management and final outcome of children with short stature and idiopathic delayed puberty. Data were obtained in 77 patients (54 males, 23 females) diagnosed and followed-up in the various centres during the last 15 years. Inclusion criteria were short stature at initial observation and idiopathic delayed puberty diagnosed during follow-up. At first observation, age was 13.8 +/- 1.0 years and height standard deviation score (SDS) was -2.6 +/- 0.6 in males. In females age was 13.1 +/- 0.9 years and height SDS -2.6 +/- 0.4. Local diagnostic and therapeutic protocols included testing for growth-hormone deficiency (six centres) and treatment in case of deficiency or, in the remaining centres, testosterone or no treatment in males, and no treatment in females. At diagnosis, both in males and in females, the auxological features (height SDS, target height SDS and bone age delay) were similar in the patients treated with growth hormone, testosterone or not treated. Overall 32 patients received growth hormone (25 males, 7 females), 33 no treatment (17 males, 16 females) and 12 testosterone. There was no difference in the adult height of males and females in the different treatment groups. In males there were no differences between adult and target height SDSs (growth hormone-treated 0.31 +/- 0.79, untreated 0.10 +/- 0.82, testosterone-treated 0.05 +/- 0.95), between adult and initial height SDSs (growth hormone-treated 1.70 +/- 0.93, untreated 1.55 +/- 0.92, testosterone-treated 1.53 +/- 1.43) and percentage of subjects with adult height above target height. In females, there were no differences between adult and target height SDSs (growth hormone-treated -0.49 +/- 1.13; untreated 0.10 +/- 0.97) and between adult and initial height SDSs (growth hormone-treated 1.76 +/- 0.92; untreated 1.77 +/- 0.98), whereas a significantly higher percentage of patients remained below target height in the growth hormone-treated group (6/7, 85.7% vs 5/11, 31.3%) (P = 0.02). In conclusion, the diagnostic and therapeutic management of the patients with short stature and delayed puberty is different among Italian pediatric endocrinologists. Our data do not support the usefulness of growth-hormone therapy in improving adult height in subjects with short stature and delayed puberty, particularly in the female sex.
Zucchini
Stefano
S
Department of Pediatrics, Azienda Ospedaliero-Universitaria di Bologna S. Orsola-Malpighi, via Massarenti 11, 40138, Bologna, Italy, zucchini@med.unibo.it.
Wasniewska
Malgorzata
M
Cisternino
Mariangela
M
Salerno
Mariacarolina
M
Iughetti
Lorenzo
L
Maghnie
Mohamad
M
Street
Maria Elisabeth
ME
Caruso-Nicoletti
Manuela
M
Cianfarani
Stefano
S
D001827:Body Height; D005260:Female; D005500:Follow-Up Studies; D006130:Growth Disorders / Q000503:physiopathology / Q000628:therapy; D019382:Human Growth Hormone / Q000172:deficiency / Q000627:therapeutic use*; D006801:Humans; D007558:Italy; D008297:Male; D011628:Puberty, Delayed / Q000175:diagnosis / Q000188:drug therapy*; D012189:Retrospective Studies; D013739:Testosterone / Q000627:therapeutic use*; D016896:Treatment Outcome
D019382:Human Growth Hormone; D013739:Testosterone
Eur J Pediatr. 1991 Aug;150(10):708-12
1915481
J Clin Endocrinol Metab. 2003 Oct;88(10):4748-53
14557450
Arch Dis Child. 1990 Oct;65(10):1109-12
2248500
Helv Paediatr Acta. 1988 Nov;43(3):171-6
3220788
J Clin Endocrinol Metab. 2000 Oct;85(10):3653-60
11061518
Clin Endocrinol (Oxf). 2006 May;64(5):510-3
16649968
Endocr Rev. 2003 Oct;24(5):668-93
14570750
Horm Res. 2003;60 Suppl 3:35-48
14671394
J Pediatr Endocrinol Metab. 1996 Sep-Oct;9(5):511-7
8961126
Growth Horm IGF Res. 2004 Jun;14(3):185-94
15125879
Acta Endocrinol (Copenh). 1992 Nov;127(5):392-6
1471449
Eur J Clin Nutr. 2002 Feb;56(2):171-80
11857051
J Endocrinol Invest. 2006 Jul-Aug;29(7):581-93
16957405
Horm Res. 2006;65(4):192-6
16549932
Horm Res. 2006;65(4):197-9
16549933
Helv Paediatr Acta. 1987 Jun;42(1):21-8
3667329
J Pediatr Endocrinol Metab. 2001 Jul;14 Suppl 2:953-7
11529401
Horm Res. 1999;51 Suppl 3:101-3
10592451
Clin Endocrinol (Oxf). 2003 Mar;58(3):267-72
12608930
Pediatr Endocrinol Rev. 2005 Jun;2(4):645-52
16208277
J Clin Endocrinol Metab. 1994 Feb;78(2):478-82
7508951
J Clin Endocrinol Metab. 2000 Nov;85(11):4168-72
11095449
J Clin Endocrinol Metab. 1995 Nov;80(11):3292-7
7593441